title: Endothelial cells support persistent gammaherpesvirus 68 infection.
abstract: A variety of human diseases are associated with gammaherpesviruses, including neoplasms of lymphocytes (e.g. Burkitt's lymphoma) and endothelial cells (e.g. Kaposi's sarcoma). Gammaherpesvirus infections usually result in either a productive lytic infection, characterized by expression of all viral genes and rapid cell lysis, or latent infection, characterized by limited viral gene expression and no cell lysis. Here, we report characterization of endothelial cell infection with murine gammaherpesvirus 68 (gammaHV68), a virus phylogenetically related and biologically similar to the human gammaherpesviruses. Endothelial cells supported gammaHV68 replication in vitro, but were unique in that a significant proportion of the cells escaped lysis, proliferated, and remained viable in culture for an extended time. Upon infection, endothelial cells became non-adherent and altered in size, complexity, and cell-surface protein expression. These cells were uniformly infected and expressed the lytic transcription program based on detection of abundant viral gene transcripts, GFP fluorescence from the viral genome, and viral surface protein expression. Additionally, endothelial cells continued to produce new infectious virions as late as 30 days post-infection. The outcome of this long-term infection was promoted by the gammaHV68 v-cyclin, because in the absence of the v-cyclin, viability was significantly reduced following infection. Importantly, infected primary endothelial cells also demonstrated increased viability relative to infected primary fibroblasts, and this increased viability was dependent on the v-cyclin. Finally, we provide evidence for infection of endothelial cells in vivo in immune-deficient mice. The extended viability and virus production of infected endothelial cells indicated that endothelial cells provided a source of prolonged virus production and identify a cell-type specific adaptation of gammaherpesvirus replication. While infected endothelial cells would likely be cleared in a healthy individual, persistently infected endothelial cells could provide a source of continued virus replication in immune-compromised individuals, a context in which gammaherpesvirus-associated pathology frequently occurs.
authors.affiliation: Department of Microbiology and Program in Molecular Biology, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.
authors.forename: Andrea Luísa
authors.initials: AL
authors.lastname: Suárez
authors.forename: Linda Faye
authors.initials: LF
authors.lastname: van Dyk
mesh_terms: D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D002478:Cells, Cultured; D016213:Cyclins; D042783:Endothelial Cells / Q000473:pathology / Q000821:virology*; D005347:Fibroblasts / Q000473:pathology / Q000821:virology; D006566:Herpesviridae Infections / Q000473:pathology*; D051379:Mice; D008969:Molecular Sequence Data; D018144:Rhadinovirus; D014412:Tumor Virus Infections / Q000473:pathology*; D014764:Viral Proteins; D014779:Virus Replication
chemical_list: D016213:Cyclins; D014764:Viral Proteins
references.citation: J Virol. 2007 Mar;81(5):2095-101
references.pmid: 16956936
references.citation: J Virol. 2006 Dec;80(24):11946-59
references.pmid: 17005668
references.citation: Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):581-93
references.pmid: 11313013
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7508-13
references.pmid: 10377445
references.citation: Trends Microbiol. 1998 Jul;6(7):276-82
references.pmid: 9717216
references.citation: J Virol. 2000 Aug;74(15):6964-74
references.pmid: 10888635
references.citation: J Virol. 1999 May;73(5):4181-7
references.pmid: 10196314
references.citation: Hum Pathol. 1984 May;15(5):430-9
references.pmid: 6327494
references.citation: Curr Opin Microbiol. 1999 Aug;2(4):403-9
references.pmid: 10458986
references.citation: Am J Gastroenterol. 1985 May;80(5):355-60
references.pmid: 2859801
references.citation: J Virol. 2003 Sep;77(17):9669-84
references.pmid: 12915579
references.citation: Nat Med. 1995 Dec;1(12):1274-8
references.pmid: 7489408
references.citation: Circ Res. 2007 Feb 2;100(2):158-73
references.pmid: 17272818
references.citation: Virol J. 2005 Feb 10;2:7
references.pmid: 15705200
references.citation: FASEB J. 2006 Jun;20(8):1045-54
references.pmid: 16770003
references.citation: J Cell Physiol. 1988 Oct;137(1):75-85
references.pmid: 3170659
references.citation: Virology. 2004 Oct 10;328(1):7-18
references.pmid: 15380353
references.citation: Acta Virol. 1980 Dec;24(6):468
references.pmid: 6111210
references.citation: Viral Immunol. 2004;17(2):308-14
references.pmid: 15279708
references.citation: J Virol. 1997 Aug;71(8):5894-904
references.pmid: 9223479
references.citation: Eur J Immunol. 1996 Feb;26(2):449-53
references.pmid: 8617317
references.citation: J Gen Virol. 1997 Jul;78 ( Pt 7):1675-87
references.pmid: 9225045
references.citation: J Virol. 2003 May;77(9):5118-26
references.pmid: 12692214
references.citation: J Cell Mol Med. 2008 Oct;12(5B):1974-89
references.pmid: 18194452
references.citation: J Virol. 2004 Apr;78(8):4278-88
references.pmid: 15047841
references.citation: J Virol. 2002 Jun;76(11):5522-31
references.pmid: 11991980
references.citation: J Virol. 2004 Feb;78(3):1063-8
references.pmid: 14722261
references.citation: Cancer Cell. 2007 Mar;11(3):245-58
references.pmid: 17349582
references.citation: Nat Immunol. 2002 Aug;3(8):733-40
references.pmid: 12101398
references.citation: J Virol. 2002 Mar;76(5):2440-8
references.pmid: 11836422
references.citation: Scand J Infect Dis Suppl. 1995;99:34-40
references.pmid: 8668941
references.citation: Am J Pathol. 1989 Jan;134(1):223-30
references.pmid: 2536523
references.citation: J Immunol. 1994 Jun 1;152(11):5208-19
references.pmid: 7514631
references.citation: J Exp Med. 1998 Jun 15;187(12):1941-51
references.pmid: 9625754
references.citation: Circulation. 2000 Aug 15;102(7):779-85
references.pmid: 10942747
references.citation: J Virol. 1996 Jun;70(6):3528-35
references.pmid: 8648686
references.citation: J Virol. 2004 Jan;78(1):197-205
references.pmid: 14671101
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10623-8
references.pmid: 12963823
references.citation: PLoS One. 2008 Jan 30;3(1):e1520
references.pmid: 18231605
references.citation: J Virol. 2007 May;81(10):5079-90
references.pmid: 17329329
references.citation: J Immunol. 2004 Sep 15;173(6):3581-8
references.pmid: 15356100
references.citation: Blood. 2006 Jul 1;108(1):141-51
references.pmid: 16543476
references.citation: Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):569-79
references.pmid: 11313012
references.citation: J Gen Virol. 1995 Apr;76 ( Pt 4):741-50
references.pmid: 9049319
references.citation: J Virol. 1996 Oct;70(10):6775-80
references.pmid: 8794315
references.citation: J Exp Med. 2004 Aug 2;200(3):391-8
references.pmid: 15289507
references.citation: J Virol. 2000 Aug;74(16):7451-61
references.pmid: 10906198
references.citation: J Virol. 1999 Aug;73(8):6892-902
references.pmid: 10400787
references.citation: J Virol. 1996 Sep;70(9):6516-8
references.pmid: 8709292
references.citation: J Virol. 2006 Dec;80(23):11539-55
references.pmid: 16987970
references.citation: J Virol. 2004 Dec;78(23):13370-5
references.pmid: 15542690
references.citation: Nature. 1998 Aug 6;394(6693):588-92
references.pmid: 9707121
references.citation: EMBO J. 2002 May 15;21(10):2418-29
references.pmid: 12006494
references.citation: J Immunol Methods. 2000 Oct 20;244(1-2):205-15
references.pmid: 11033033
references.citation: PLoS Pathog. 2006 Oct;2(10):e107
references.pmid: 17238276
references.citation: J Virol. 1987 Jul;61(7):2198-207
references.pmid: 3035220
references.citation: J Virol. 1998 Jul;72(7):5661-8
references.pmid: 9621025
references.citation: Circ Res. 2007 Feb 2;100(2):174-90
references.pmid: 17272819
references.citation: J Virol. 1993 Sep;67(9):5247-52
references.pmid: 8394447
references.citation: Science. 1994 Jul 15;265(5170):391-4
references.pmid: 8023160
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3805-10
references.pmid: 15738413
references.citation: Cancer Res. 2001 Mar 15;61(6):2641-8
references.pmid: 11289142
references.citation: Blood. 2006 Sep 15;108(6):1932-40
references.pmid: 16601245
references.citation: Cancer Cell. 2006 Aug;10(2):133-43
references.pmid: 16904612
references.citation: J Virol. 2002 Jul;76(14):7125-32
references.pmid: 12072512
references.citation: Trends Cardiovasc Med. 2005 Jul;15(5):174-84
references.pmid: 16165014
references.citation: Nat Genet. 2004 Jul;36(7):683-5
references.pmid: 15220917
references.citation: J Immunol. 2004 Mar 15;172(6):3850-9
references.pmid: 15004192
references.citation: Cancer Cell. 2003 Jan;3(1):23-36
references.pmid: 12559173
references.citation: J Immunol Methods. 2003 Dec;283(1-2):307-15
references.pmid: 14659921
references.citation: Nat Genet. 2004 Jul;36(7):687-93
references.pmid: 15220918
references.citation: J Virol. 2004 May;78(10):5103-12
references.pmid: 15113892
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3366-71
references.pmid: 17360652
references.citation: J Virol. 1999 Jun;73(6):5110-22
references.pmid: 10233974
references.citation: Curr Opin Microbiol. 2002 Aug;5(4):403-7
references.pmid: 12160860
references.citation: J Virol. 2001 Jun;75(12):5614-26
references.pmid: 11356969
references.citation: J Exp Med. 1979 Sep 19;150(3):580-96
references.pmid: 90108
references.citation: J Immunol. 1989 Oct 15;143(8):2714-22
references.pmid: 2794510
references.citation: Cancer Res. 1990 Dec 1;50(23):7686-96
references.pmid: 2253213
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):690-4
references.pmid: 9012846